logo-loader
AIM:MTFB

Motif Bio PLC

Receive alerts
Market:
AIM
Market Cap:
£5.9 m
Price
0.90 GBX
Change
-5.74%
52 weeks high
9.70
52 weeks low
0.03

In brief

Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.